Ipratropium Bromide And Albuterol Sulfate
Generic Name: ipratropium bromide and albuterol sulfate
Brand Names:
Ipratropium Bromide And Albuterol Sulfate
Ipratropium bromide and albuterol sulfate is a combination inhalation solution containing an anticholinergic bronchodilator and a beta-2 adrenergic bronchodilator for the treatment of bronchospasm associated with COPD.
Overview
Ipratropium bromide and albuterol sulfate is a combination inhalation solution containing an anticholinergic bronchodilator and a beta-2 adrenergic bronchodilator for the treatment of bronchospasm associated with COPD.
Uses
Indicated for treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
Dosage
One 3 mL vial administered 4 times daily via nebulization, with up to 2 additional doses allowed daily if needed. Administered via jet nebulizer with mouthpiece or face mask.
Side Effects
Common: lung disease, pharyngitis, chest pain, leg cramps, diarrhea, bronchitis. Less common: nausea, dyspepsia, urinary tract infection. Possible allergic reactions include skin rash and urticaria.
Interactions
Caution with anticholinergic agents, other sympathomimetics, beta-blockers, non-potassium sparing diuretics, MAOIs, and tricyclic antidepressants.
Warnings
Risk of paradoxical bronchospasm (potentially life-threatening). Do not exceed recommended dose. Cardiovascular effects possible. Avoid eye exposure. Immediate hypersensitivity reactions may occur. Contraindicated in patients with hypersensitivity to components or atropine derivatives.
Pregnancy
Albuterol: Pregnancy Category C (teratogenic in mice). Ipratropium: Pregnancy Category B (no teratogenicity at studied doses). Use only if benefit justifies risk. Unknown if components pass into breast milk.
Storage
Store between 2-25 degrees C (36-77 degrees F). Protect from light. Keep vials in foil pouch until use.
Frequently Asked Questions
What is Ipratropium Bromide And Albuterol Sulfate used for?▼
Indicated for treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
What are the side effects of Ipratropium Bromide And Albuterol Sulfate?▼
Common: lung disease, pharyngitis, chest pain, leg cramps, diarrhea, bronchitis. Less common: nausea, dyspepsia, urinary tract infection. Possible allergic reactions include skin rash and urticaria.
Can I take Ipratropium Bromide And Albuterol Sulfate during pregnancy?▼
Albuterol: Pregnancy Category C (teratogenic in mice). Ipratropium: Pregnancy Category B (no teratogenicity at studied doses). Use only if benefit justifies risk. Unknown if components pass into breast milk.
What are the important warnings for Ipratropium Bromide And Albuterol Sulfate?▼
Risk of paradoxical bronchospasm (potentially life-threatening). Do not exceed recommended dose. Cardiovascular effects possible. Avoid eye exposure. Immediate hypersensitivity reactions may occur. Contraindicated in patients with hypersensitivity to components or atropine derivatives.
Related Medications
Rose Bengal Sodium
rose bengal sodium
Rose Bengal Ophthalmic Strips diagnostic agent is for professional use only Each strip is impregnated with 1.3 mg of Rose Bengal.
Grass Mix 8
grass mix 8
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: AGROSTIS GIGANTEA POLLEN (100000 [BAU]/mL); CYNODON DACTYLON POLLEN (10000 [BAU]/mL); PHLEUM PRATENSE POLLEN (100000 [BAU]/mL); POA PRATENSIS POLLEN (100000 [BAU]/mL); SORGHUM HALEPENSE POLLEN (.05 g/mL). Category: BLA.
Perampanel
perampanel
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
11 DESCRIPTION Perampanel tablets contain perampanel a non-competitive AMPA receptor antagonist as a 4:3 hydrate. The chemical name of the active ingredient is 2-(1´,6´-dihydro-6´-oxo-1´-phenyl[2,3´-bipyridin]-5´-yl)-benzonitrile, hydrate (4:3). The molecular formula is C 23 H 15 N 3 O ∙ ¾H 2 O, and the molecular weight is 362.90 (349.39 for anhydrous perampanel). It is a white to yellowish white powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.